A new look at the statistical model identification, IEEE Transactions on Automatic Control, vol.19, issue.6, pp.716-723, 1974. ,
DOI : 10.1109/TAC.1974.1100705
Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme, Journal of Clinical Oncology, vol.23, issue.10, pp.2372-2377, 2005. ,
DOI : 10.1200/JCO.2005.00.331
The in vitro radiosensitivity of human head and neck cancers, British Journal of Cancer, vol.77, issue.12, 1998. ,
DOI : 10.1038/bjc.1998.394
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies, British Journal of Cancer, vol.81, issue.6, pp.1022-1030, 1999. ,
DOI : 10.1038/sj.bjc.6690802
Years of life lost (YLL) from cancer is an important measure of population burden ??? and should be considered when allocating research funds, British Journal of Cancer, vol.6, issue.2, pp.241-245, 2005. ,
DOI : 10.1038/sj.bjc.6602321
Mathematical Modelling of Survival of Glioblastoma Patients Suggests a Role for Radiotherapy Dose Escalation and Predicts Poorer Outcome After Delay to Start Treatment, Clinical Oncology, vol.18, issue.2, pp.93-103, 2006. ,
DOI : 10.1016/j.clon.2005.08.017
Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms, Clinical Cancer Research, vol.12, issue.15, pp.4738-4746, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-0596
Randomized phase III trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma, J. Clin. Oncol, issue.23, pp.27-3861, 2009. ,
Brain Tumors, New England Journal of Medicine, vol.344, issue.2, pp.114-123, 2001. ,
DOI : 10.1056/NEJM200101113440207
Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer, Gynecologic Oncology, vol.94, issue.1, pp.121-124, 2004. ,
DOI : 10.1016/j.ygyno.2004.03.034
Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model, Cell Proliferation, vol.136, issue.4, pp.511-528, 2009. ,
DOI : 10.1111/j.1365-2184.2009.00613.x
The linear-quadratic formula and progress in fractionated radiotherapy, The British Journal of Radiology, vol.62, issue.740, pp.679-94, 1989. ,
DOI : 10.1259/0007-1285-62-740-679
Development of radiobiology for oncology???a personal view, Physics in Medicine and Biology, vol.51, issue.13, pp.263-286, 2006. ,
DOI : 10.1088/0031-9155/51/13/R16
2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile, European Journal of Cancer Supplements, vol.5, issue.4, pp.232-233, 2007. ,
DOI : 10.1016/S1359-6349(07)70921-7
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3, The Lancet Oncology, vol.9, issue.1, pp.26981-22981, 2008. ,
DOI : 10.1016/S1470-2045(07)70384-4
Radiobiology for the radiologist, 2006. ,
Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies, Journal of Clinical Oncology, vol.17, issue.8, pp.17-2604, 1999. ,
DOI : 10.1200/JCO.1999.17.8.2604
Derivation of the optimum dose per fraction from the linear quadratic model, The British Journal of Radiology, vol.68, issue.812, pp.894-902, 1995. ,
DOI : 10.1259/0007-1285-68-812-894
Mathematical Models of Tumour and Normal Tissue Response, Acta Oncologica, vol.10, issue.7, pp.883-893, 1999. ,
DOI : 10.3109/02841868409136037
The role of biologically effective dose (BED) in clinical oncology, Clin. Oncol, vol.13, issue.2, pp.71-81, 2001. ,
The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy, The British Journal of Radiology, vol.78, issue.934, pp.939-944, 2005. ,
DOI : 10.1259/bjr/40226390
Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.2, pp.441-448, 2007. ,
DOI : 10.1016/j.ijrobp.2006.12.025
In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide, Clinical Cancer Research, vol.14, issue.3, pp.931-938, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1856
Nonparametric estimation from incomplete observations, 1958. ,
DOI : 10.1007/978-1-4612-4380-9_25
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma, New England Journal of Medicine, vol.340, issue.15, pp.340-1154, 1999. ,
DOI : 10.1056/NEJM199904153401503
Modelling and simulation of radiotherapy, Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol.255, issue.1, pp.13-17, 2007. ,
DOI : 10.1016/j.nimb.2006.11.005
A mathematical model of the treatment and survival of patients with high-grade brain tumours, Journal of Theoretical Biology, vol.245, issue.1, pp.112-124, 2007. ,
DOI : 10.1016/j.jtbi.2006.09.007
Pathology & genetics of tumours of the nervous system. World Health Organisation classification of tumours, 2000. ,
Radiotherapy of primary malignant brain tumors, Seminars in Surgical Oncology, vol.17, issue.1, pp.34-42, 1998. ,
DOI : 10.1002/(SICI)1098-2388(199801/02)14:1<34::AID-SSU5>3.0.CO;2-3
The charing cross hospital experience with temozolomide in patients with gliomas, European Journal of Cancer, vol.32, issue.13, pp.32-2236, 1996. ,
DOI : 10.1016/S0959-8049(96)00258-4
Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients, Clinical Oncology, vol.21, issue.7, pp.515-524, 2009. ,
DOI : 10.1016/j.clon.2009.05.003
Principles and Practice of Radiation Oncology, Journal of Pediatric Hematology/Oncology, vol.21, issue.6, 1998. ,
DOI : 10.1097/00043426-199911000-00025
Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy, Physics in Medicine and Biology, vol.52, issue.11, pp.52-3291, 2007. ,
DOI : 10.1088/0031-9155/52/11/023
An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor, International Journal of Radiation Oncology*Biology*Physics, vol.64, issue.5, pp.1570-1580, 2006. ,
DOI : 10.1016/j.ijrobp.2005.12.022
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer, New England Journal of Medicine, vol.340, issue.15, pp.340-1144, 1999. ,
DOI : 10.1056/NEJM199904153401502
Estimating the Dimension of a Model, The Annals of Statistics, vol.6, issue.2, pp.461-464, 1978. ,
DOI : 10.1214/aos/1176344136
Concomitant (without Adjuvant) Temozolomide and Radiation to Treat Glioblastoma: a Retrospective Study, Clinical Oncology, vol.21, issue.1, pp.19-22, 2009. ,
DOI : 10.1016/j.clon.2008.08.008
The radiation biology of paediatric tumours, Paediatric Oncology, 1991. ,
Basic clinical radiobiology, 2002. ,
Antitumour Imidazotetrazines. 1. Synthesis and chemistry of 8- Carbamoyl-3-(2-chloroethyl)imidazol(3H)-one, a novel broadspectrum antitumor agent, J. Med. Chem, vol.51123, issue.27, pp.5-9, 1984. ,
Antitumor activity and pharmacokinetics in mice of 8-Carbamoyl-3- methyl-imidazo, 81045; M & B 39831), a novel drug with potential as an alternative to decarbazine, pp.5-9, 1987. ,
Radiotherapy plus concomitant and adjuvant temozolomide for gliobalstoma, N. Eng. J. Med, issue.10, pp.352-987, 2005. ,
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery, 2002. ,
Temozolomide (TMZ) concomitant to radiotherapy (RT) plus 12 cycles of maintenance chemotherapy in newly diagnosed GBM: is more better? Eur, J. Canc, vol.5, issue.4, p.229, 2007. ,
A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth, Cell Proliferation, vol.32, issue.1, pp.17-31, 1995. ,
DOI : 10.1016/S0022-5193(87)80171-6
Temozolomide in malignant gliomas: current use and future targets, Cancer Chemotherapy and Pharmacology, vol.31, issue.4, pp.647-655, 2009. ,
DOI : 10.1007/s00280-009-1050-5
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas, International Journal of Radiation Oncology*Biology*Physics, vol.5, issue.10, pp.1725-1731, 1979. ,
DOI : 10.1016/0360-3016(79)90553-4
Chapter 1: summary, Acta Oncol, vol.35, issue.S6, pp.9-23, 1996. ,
A review of ?/? ratios for experimental tumours: implications for clinical studies of altered fractionation Basic clinical radiobiology, 1985. ,